Latest News
Investor Relations
Latest News
June 23, 2025 08:17 am
BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers
June 17, 2025 08:59 am
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
June 3, 2025 07:00 am
BioStem Technologies Provides Update on the Company's Form 10 Submission and SEC Review Process
May 29, 2025 07:00 am
BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 28, 2025 07:00 am
BioStem Announces Notice of Allowance for Three New U.S. Patent Applications
May 22, 2025 07:00 am
Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist
May 12, 2025 04:00 pm
BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results
May 1, 2025 07:00 am
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
April 30, 2025 07:00 am
BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
April 21, 2025 07:07 am